Audio

Dr. Swamy speaks of the history of burnout that preceded the pandemic, and how physicians are struggling with emotional, mental, and physical trauma from COVID-19.

The institute will assemble and support a diverse, multidisciplinary team of scientists and researchers to lead the charge breakthroughs in airway science.

The Temple-based investigator and expert joins Lungcast to review recent clinical trials, recommendations and non-surgical techniques for patients who have advanced COPD.

Dr. Ivy speaks on promising new therapies and training for sickle cell management during the first blood shortage in the United States in 10 years.

Dr. Siddharthan speaks of high COPD rates in low- and middle-income countries with increased environmental exposures and a lack of diagnostic tools.

Dr. Talbot speaks to the variety of different strains of influenza, and how research into different flu vaccines could be informed by advancements made in the management of shingles and COVID-19.

Dr. Silverberg speaks of the recent FDA approval of the biologic for patients with moderate-to-severe atopic dermatitis.

Manesh Patel, MD, and his colleague Rymer delve into the most impactful and interesting trials presented at the Fall cardiovascular meetings.

Complex ADHD along with other comorbid psychiatric conditions increases the risk of mortality for patients.

Dr. Al Rizzo highlights the best insights and opinions from featured guests this last year.

Dr. Moody speaks to how these E/M code changes affect billing documentation and patient care.

Dr. Jellinger discusses the lipid section of the DCRM guidelines, the role of combination therapies in lowering LDL and what is coming next for the field of diabetes in 2022.

With the concept of a “twindemic” becoming more realistic than ever, experts are stressing that preventive practices, and vaccination, address both flu and COVID-19.

Donald Alcendor, PhD, joins to review currently available data surrounding the newest COVID-19 variant of concern, and shares guidance for concerned clinicians and the general public.

In recognition of Lung Cancer Awareness Month, this episode featuring Dr. James Mulshine at Rush University explains the ins and outs of the improved 2021 lung cancer screening guidelines.

The Director of Retina Services at Wills Eye Hospital joins to discuss the historic FDA approval granted for a novel method of ophthalmic care: a permanent implant that allows for vision-saving formula therapy to treat the eye continually.

Investigators found 11.9% of patients with IBD in a survey were considered vaccine hesitant.

ILD is a very broad category of chronic lung conditions with considerable nuance. Glassberg joins to discuss the roles of biomarkers, biopsies and drugs, as well as multidisciplinary clinics and stem cell therapy.

Josh Mali, MD, of The Eyes Associates, joins HCPLive to review the key news and developments coming out of the American Society of Retina Specialists 2021 Scientific Meeting.

Michael Greenberg, MD, MPH, and Rick Nettles, MD, join Lungcast to discuss COVID-19 vaccine development, the 2021-22 flu season, RSV outbreaks, and more respiratory viruses.

Dr. Yamalis Diaz said ADHD is often under-diagnosed.

Dr. Castro defines type 2 inflammation and the complications surrounding severe asthma, as well as several biomarkers including IgE levels, blood eosinophils, and exhaled nitric oxide.

Manesh Patel, MD, kicks off his first podcast by discussing HFpEF findings in EMPEROR-Preserved, the GUIDE-HF trial and more with his Duke colleague.

The FODMAP diet is considered a preferable option for patients with irritable bowel syndrome.

In this episode of Derm Discussions, vitiligo expert John Harris, MD, PhD, discusses new tactics and therapeutic options in treating inflammatory skin disorders like vitiligo, alopecia areata, and atopic dermatitis.

Dr. Castro and Dr. Rizzo discuss the evolving world of monoclonal antibodies for severe asthma. Plus, the ALA team discusses September's annual Asthma Peak Week, and what it means for reopening schools.

Sharon Hrynkow, PhD, joins the Rare Disease Report to discuss the ultra rare and heterogenous lysosomal storage disorder.

On the latest Derm Discussions, Brett King, MD, PhD, joins Brad Glick, DO, to discuss the potential of the JAK inhibitor class for dermatology.

Andrea Mazzocchi, PhD, explains how tissue and blood samples can be used to improve detection, progression, and treatment for cancer in patients.

The co-founder and CEO of Known Medicine dissects the art and science of how profiling biomarkers, epigenetics and the microenvironment may provide the synergy needed to revolutionize the oncologic landscape.